Dietary butyrate delivery systems: NestleRecent Research Landscape
Uncontrolled volatility and rapid metabolism of short-chain fatty acids limit therapeutic bioavailability. Engineering specific butyrate delivery forms ensures targeted intestinal release and systemic absorption.
What technical problems is Nestle addressing in Dietary butyrate delivery systems?
Inadequate gastrointestinal butyrate delivery
(14)evidences
Butyrate is typically absorbed in the stomach and small intestine before reaching the colon. Preventing early uptake ensures therapeutic concentrations reach the distal gut.
Premature upper gastrointestinal absorption
(3)evidences
Free butyric acid possesses an extremely offensive odor and acrid taste that prevents consumer acceptance. Eliminating these sensory barriers allows for the incorporation of effective dosages into functional foods.